Catalyst Pharmaceuticals
CPRX
$16.17
Share price
0.37%
Change (1 day)
38.92%
Change (1 year)
Categories
Market capitalization of Catalyst Pharmaceuticals (CPRX)
Market cap: $1.90 Billion
As of June 2024 Catalyst Pharmaceuticals has a market cap of $1.90 Billion. This makes Catalyst Pharmaceuticals the world's 4196th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Catalyst Pharmaceuticals from 2006 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.90 B | 6.57% |
| 2023 | $1.79 B | -7.42% |
| 2022 | $1.93 B | 177.62% |
| 2021 | $0.69 B | 101.15% |
| 2020 | $0.34 B | -10.6% |
| 2019 | $0.38 B | 96.56% |
| 2018 | $0.19 B | -50.77% |
| 2017 | $0.40 B | 360.32% |
| 2016 | $87.04 M | -57.12% |
| 2015 | $0.20 B | -1.12% |
| 2014 | $0.20 B | 94.47% |
| 2013 | $0.10 B | 485.85% |
| 2012 | $18.01 M | -43.45% |
| 2011 | $31.86 M | 65.96% |
| 2010 | $19.2 M | 68.96% |
| 2009 | $11.36 M | -55.1% |
| 2008 | $25.3 M | -41.44% |
| 2007 | $43.22 M | -28.51% |
| 2006 | $60.45 M |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Catalyst Pharmaceuticals was reported to be:
$1.90 Billion
$1.90 Billion
$1.90 Billion
$1.90 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.98 B | 18,381.81% | 🇺🇸 USA |
 Pfizer PFE | $162.40 B | 8,403.21% | 🇺🇸 USA |
 Abbott Laboratories ABT | $177.77 B | 9,207.87% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $12.27 B | 542.69% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.96% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.25 B | 646.33% | 🇺🇸 USA |